Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay S Raval

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Transfusion|July 16, 2021
Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injuryJay S Raval, Kathleen M Madden, Matthew D Neal, et al.
Transfusion|October 15, 2013
Simultaneous extracorporeal membrane oxygenation and therapeutic plasma exchange procedures are tolerable in both pediatric and adult patientsMitchell Dyer, Matthew D Neal, Marian A Rollins-Raval, et al.
Journal of Clinical Apheresis|July 20, 2012
Plasma exchange in a 13-year-old male with acute intravascular hemolysis and acute kidney injury after placement of a ventricular assist deviceJay S Raval, Peter D Wearden, Richard A Orr, et al.
Therapeutic Advances in Neurological Disorders|December 30, 2025
Shaping the role of plasma exchange in autoimmune neurology: lessons learned from 67 years and over 90,000 proceduresBhupendra O Khatri, Regina Berkovich, Jay S Raval, et al.
Transfusion Medicine Reviews|February 26, 2013
Innate immune activation after transfusion of stored red blood cellsMatthew D Neal, Jay S Raval, Darrell J Triulzi, et al.
Journal of Clinical Apheresis|November 19, 2017
Treatment of acquired Thrombotic Thrombocytopenic Purpura in the U.S. remains heterogeneous: Current and future points of clinical equipoiseMarshall A Mazepa, Jay S Raval, Mark E Brecher, et al.
Transfusion|July 30, 2014
How we approach an acquired thrombotic thrombocytopenic purpura patientJay S Raval, Marshall A Mazepa, Mark E Brecher, et al.
The Korean Journal of Hematology|January 16, 2013
Complications following an unnecessary peri-operative plasma transfusion and literature reviewJay S Raval, Jonathan H Waters, Darrell J Triulzi, et al.
Thrombosis Research|December 25, 2021
Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?Nathan D Nielsen, Marian A Rollins-Raval, Jay S Raval, et al.
British Journal of Haematology|December 19, 2013
Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpuraMarshall A Mazepa, Jay S Raval, Stephan Moll, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Transfusion|July 16, 2021
Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injuryJay S Raval, Kathleen M Madden, Matthew D Neal, et al.
Transfusion|October 15, 2013
Simultaneous extracorporeal membrane oxygenation and therapeutic plasma exchange procedures are tolerable in both pediatric and adult patientsMitchell Dyer, Matthew D Neal, Marian A Rollins-Raval, et al.
Journal of Clinical Apheresis|July 20, 2012
Plasma exchange in a 13-year-old male with acute intravascular hemolysis and acute kidney injury after placement of a ventricular assist deviceJay S Raval, Peter D Wearden, Richard A Orr, et al.
Therapeutic Advances in Neurological Disorders|December 30, 2025
Shaping the role of plasma exchange in autoimmune neurology: lessons learned from 67 years and over 90,000 proceduresBhupendra O Khatri, Regina Berkovich, Jay S Raval, et al.
Transfusion Medicine Reviews|February 26, 2013
Innate immune activation after transfusion of stored red blood cellsMatthew D Neal, Jay S Raval, Darrell J Triulzi, et al.
Journal of Clinical Apheresis|November 19, 2017
Treatment of acquired Thrombotic Thrombocytopenic Purpura in the U.S. remains heterogeneous: Current and future points of clinical equipoiseMarshall A Mazepa, Jay S Raval, Mark E Brecher, et al.
Transfusion|July 30, 2014
How we approach an acquired thrombotic thrombocytopenic purpura patientJay S Raval, Marshall A Mazepa, Mark E Brecher, et al.
The Korean Journal of Hematology|January 16, 2013
Complications following an unnecessary peri-operative plasma transfusion and literature reviewJay S Raval, Jonathan H Waters, Darrell J Triulzi, et al.
Thrombosis Research|December 25, 2021
Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?Nathan D Nielsen, Marian A Rollins-Raval, Jay S Raval, et al.
British Journal of Haematology|December 19, 2013
Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpuraMarshall A Mazepa, Jay S Raval, Stephan Moll, et al.
Pageof 15